We have demonstrated Th2 clonal anergy as a consequence of partial T cell activation by immunogenic peptide and chemically fixed APC, as well as by altered peptide ligand and live antigen-presenting cells (APC). Either stimulation resulted in a profound inability of the T cells to proliferate upon restimulation with antigen and functional APC, a similar phenomenon to that found with Thl cells. The anergic state was long lasting and was restricted to proliferation, since the T cells retained the ability to produce cytokines upon restimulation, albeit at slightly reduced levels. Th2 anergy induction was inhibited by cyclosporine A, but not by provision of exogenous costimulation or growth factors. The data presented unify Thl and Th2 cells with regard to anergy and suggest that the fundamental control during anergy for both subsets is prevention of donal expansion, thus blocking amplification of the immune response. C D4 T cells require TCR engagement by an immunogenic peptide bound to a class II MHC molecule, as well as a costimulus provided by the APC, for successful activation leading to clonal expansion (1, 2). Although the nature of the costimulus has not been completely elucidated, substantial evidence has accumulated implicating the B7-CD28 interaction in the Thl subset (3), whereas IL-1 has been shown to have costimulatory activity for Th2 cells (4-7). In the Thl subset, it has been dearly shown that TCR engagement without costimulation does not provide adequate signaling to induce proliferation (8-10). Interestingly, such an interaction leads to a state of profound unresponsiveness in these T cells upon restimulation, a phenotype known as T cell anergy (9-12). This unresponsive state appears to result from TCR triggering without T cell proliferation (13) and can be prevented by providing exogenous costimulation during the initial TCR engagement (3, 14) . More recently, we have demonstrated that stimulation of Thl dories with altered peptide ligands (APL) 1 and live APC, a combination that partially activates the T cells but does not induce proliferation, also results in unresponsiveness to future stimulation with the immunogenic peptide (15). Addition of exogenous costimulation does not prevent anergy from occurring in this situation, suggesting that a signaling event more proximal to the TCR is responsible for inducing unresponsiveness here (16). Although the intraceUular events involved are not yet 1 Abbreviations used in this paper: APL, altered peptide ligands; ECD1, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; HEL, hen egg white lysozyme; RT, reverse transcriptase. revealed, it is clear that T cells of the Thl subset can be made functionally unresponsive for prolonged periods of time.
C
D4 T cells require TCR engagement by an immunogenic peptide bound to a class II MHC molecule, as well as a costimulus provided by the APC, for successful activation leading to clonal expansion (1, 2) . Although the nature of the costimulus has not been completely elucidated, substantial evidence has accumulated implicating the B7-CD28 interaction in the Thl subset (3), whereas IL-1 has been shown to have costimulatory activity for Th2 cells (4) (5) (6) (7) . In the Thl subset, it has been dearly shown that TCR engagement without costimulation does not provide adequate signaling to induce proliferation (8) (9) (10) . Interestingly, such an interaction leads to a state of profound unresponsiveness in these T cells upon restimulation, a phenotype known as T cell anergy (9) (10) (11) (12) . This unresponsive state appears to result from TCR triggering without T cell proliferation (13) and can be prevented by providing exogenous costimulation during the initial TCR engagement (3, 14) . More recently, we have demonstrated that stimulation of Thl dories with altered peptide ligands (APL) 1 and live APC, a combination that partially activates the T cells but does not induce proliferation, also results in unresponsiveness to future stimulation with the immunogenic peptide (15) . Addition of exogenous costimulation does not prevent anergy from occurring in this situation, suggesting that a signaling event more proximal to the TCR is responsible for inducing unresponsiveness here (16) . Although the intraceUular events involved are not yet 1 Abbreviations used in this paper: APL, altered peptide ligands; ECD1, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; HEL, hen egg white lysozyme; RT, reverse transcriptase. revealed, it is clear that T cells of the Thl subset can be made functionally unresponsive for prolonged periods of time.
In contrast to the extensive studies of Thl cell anergy, few investigations have been published that use similar protocols in the Th2 subset. From the limited data available, it has been generally accepted that Th2 cells are not susceptible to anergy induction after TCR occupancy without costimulation (2, 17, 18) . Moreover, anti-CD3 antibody induces unresponsiveness to IL-2-driven proliferation in Thl but not Th2 clones (9) , and anergy-inducing stimuli do not result in an autocrine growth factor production defect in Th2 cells (19) . Although the reason for this contrast in phenotype is unclear, one could ascribe it to the different intracellular signaling pathways activated after stimulation of the two T cell subsets, use of different costimulators or growth factors, or a combination of these (5, 6, 20) . One study has demonstrated a correlation between the presence of IL-4 and the resistance to tolerance induction, both at the clonal level and in naive T cell populations (18) .
We reasoned that if anergy plays a significant role in T cell tolerance, then anergy should also be inducible in Th2 cells. We decided to explore the susceptibility to tolerance induction of Thl and Th2 clones with identical antigen/MHC specificity, namely, Hb(64-76)/I-E k. We have previously shown that the Thl clones could be made anergic after presentation of immunogenic peptide and chemically fixed APC or by presentation of APL and live APC (15) . In this report we show the results obtained when analogous experiments were undertaken with the Th2 cells. Our data demonstrate that antigen presentation by chemically fixed APC does indeed result in subsequent anergy of these Th2 cells to restimulation with functional APC and antigen. Moreover, we show that stimulation of these T calls with live APC and APL, which stimulates cytokine production but not proliferation, also results in an anergic phenotype upon restimulation with the immunogenic peptide. This extends our earlier observations with Thl clones to include Th2 clones and implies that the anergic state is important for both Thl and Th2 cells.
Mat~riah and Methods
M/c~ Female CBA/J and B10.BR/SgSnJ (referred to as B10.BR) mice were purchased from National Cancer Institute (Bethesda, MD) or The Jackson Laboratory (Bar Harbor, ME) and used at 5-10 wk of age.
Ag and Antisera. The Hbd(64-76) peptide, APL, and conalbumin peptide were synthesized with a RAMPS apparatus (DuPont, W'Rmington, DE), purified by reverse-phase HPLC, and amino add content confirmed by analysis on an amino add analyzer (modal 6300, Beckman, Palo Alto, CA). APL is the name ascribed to analogs of immunogenic peptides in which the TCR contact residues have been manipuhted. These peptides do not stimulate T cell-proliferative responses, but they do bind to the MHC molecules with similar affinities as the wild-type peptide, stimulating some, but not all, TCR-mediated effector functions (16) . The amino acid sequence for the Hb(64-76) peptide shown in the one-letter amino acid code is GKKVITAFNEGLK. The APL each contain a single amino add substitution; for example, the Asp73 APL contains an aspartate in place of glutamate at position 73. The amino acid sequence for the conalbumin peptide shown in the one-letter amino acid code is LLHWGAIEWEGIESG (21) . mAb specific for Ib2 (S4B6; 22), Ib4 (111311; American Type Culture Collection, Rockville, MD) and CD3e (23) were used as culture supernatants from the respective hybridoma cell lines.
Cell Lines. We have previously described the generation and characterization of a pand of Fib-reactive Th clones, including the Th2 2.102 and EWSX clones (24) . The Th clones were propagated on a 2-wk restimulation protocol by use of irradiated (2,000 tad) CBA/J splenocytes as a source of APC and endogenous antigen in R.PMI 1640 medium containing 10% fetal bovine serum (Hydone, Logan, UT), 2 mM ghtamine, 50/~g/ml gentamycin, Hepes buffer, 2-ME (2 x 10 -s M), and IL-2 (20 U/ml, supernatants from P815 transfectants expressing the gene for routine I1r 25) . The T cell hybridoma, G2, was made by use of a standard fusion protocol with the Th2 clone, 2.102, (7 d after activation) and the c~-B-BW5147 fusion partner (26, 27) . The Th2 clone D10 has been described dsewhere (28) . It was propagated as described above, with conalbumin protein (100 #g/ml) as antigen. The CH27 B ceU lymphoma, which expresses H-2 k, BT, and ICAM-1, was used as an APC source for the tolerance induction assays using live APC (27) (Fig. 2 , A and C) or for the times indicated, in 24-well tissue culture plates in a final volume of I nil. T cells were then separated from APC as described (15) , before being challenged in a proliferation assay using either 5 x 104 T cells/well and Hb(64-76) as antigen or antiCD3e mAb (2Cll) culture supematant and Ib2 (20 U/ml). Where indicated, cyclosporine A (1/~g/ml; Sandoz, Basel, Switzerhnd), rlL-1B (50 pg/ml), Ib2, or IL.-4 (20 tmits/ml) (25) were _~ld~ during the tolerance induction stage. For tolerance induction with live and analog peptides, the protocol was as above, except that mitomycin C-treated (77/zl/ml, 90 min at 37~ CH27 B lymphoma cells were used as APC (3 x 10s/well), and analog peptides were added as indicated (100/~M).
Lymphokine Assays. The lymphokine responses of the Th2 clones were assessed by use of 24-h supernatants from cultures of proliferation assays. II.,4 was quantitated in a bioassay as proliferation of the II;,2/ID4-dependent CTLb2 cell line (29) were incubated in 24-well tissue culture phtes at 37~ alone, with immobilized anti-CD3e mAb (200/~l/well prebound for 6 h, then the excess washed off with I-IB$S), or with CH27 B lymphoma cells (3 x 10s/well) and 10/~M Hb(64-76) for 14 h, after which total RNA was extracted as described (31) , and dissolved in water. Cytokine mRNA was detected by reverse transcriptase (RT) of the mRNA, followed by a PCR. First, strand cDNA was made in a 20-/~1 reaction, by use of 1/~g of total RNA as temphte, an oligodT prime~ and the superscript RT enzyme (GIBCO BRL, Gaithersburg, MD). The PCR (32) was then used to amplify cDNA of Ib2, IL-4, and the VB1 TCK chain by use ofa thermocycler (~m/~ Tronic; Thermolyne, Dubuque, IA). All oligonucleotide primers used to amplify cytokine cDNA span introns and the sequences and amplification conditions are provided dsewhere (33) . Nucleotide sequences for primers used to amplify VB1 cDNA are as follows: VB1 primer sequence is 5'GTC~C,C"IGCAC, C, CT~-TCCT 3'; C~1 primer sequence is 5'GAGC~TAGCCTTTTG-TTTGTT'IGCAAT 3' (a gift from Kenneth M. Murphy, Washington University). All oligonucleotide primers were gener-ated with a DNA synthesizer (Oligo 1000; Beckman, Fullerton, CA). Amplified bands were analyzed on 3% agarose gels (NuSieve; FMC Corp., Rockland, ME).
Results

Antigen Presentation by Chemically Fixed Splenocytes Does Not
Activate Th2 CellProliferation. Although presentation to Thl cells of an antigenic peptide by chemically fixed spleen cell APC does not support clonal expansion, reports suggest that Th2 cells can proliferate well to such a stimulus (17) . We decided to directly examine the Th2 response to antigen and fixed APC, since the published data suggested a striking difference in activation requirements by the two Th cell subsets. The Th2 clone 2.102 recognizes the immunogenic peptide of the murine hemoglobin fla minor chain, Hb(64-76), bound to an I-E t molecule, and has been exclusively characterized (24, 34) . Irradiated B10.BR splenocytes and Hb(64-76) peptide stimulated a vigorous proliferative response from 2.102 cells. In marked contrast, however, presentation of the immunogenic peptide by chemically fixed spleen cells did not induce any detectable proliferation from these T cells ( Fig.  1 A) . This phenotype was surprising since it differed from that reported for other Th2 clones (17) . However, this lack of proliferation was not simply due to a shift in the antigen dose curve, since presentation of up to 100/~M peptide by these APC (>100-fold excess of the 50% maximal response using irradiated spleen cell APC) did not stimulate any clonal expansion of the 2.102 cells (data not shown). Whereas the signal delivered to the T cells by antigen and fixed APC was inadequate to stimulate proliferation, the amount of IL-4 produced was normal (or only slightly decreased in some experiments), whereas IL-3 production was somewhat reduced (Fig. 1 , B and C). This phenotype resembles that of Thl cell reactivity to antigen presentation by fixed APC, and therefore suggests the absence of a costimulus that is required for proliferation and maximal IL-3 production, but not IL-4 production.
Antigen Presentation by Chemically Fixed Splenocytes Induces
Anergy of Th2 Cells to Subsequent Stimulation with Functional
APC. The observation that chemically fixed APC failed to stimulate Th2 cell proliferation, but supported cytokine production, raised the possibility that antigen recognition in this way might lead to unresponsiveness in these T cells. To test this, 2.102 cells were preincubated overnight with chemically fixed B10.BR splenocytes, with or without antigen, and restimulated with fresh irradiated spleen cells and antigen. Whereas T cells that had been preincubated with fixed APC alone were able to proliferate normally during the secondary stimulation, those that had been preincubated with fixed APC and antigen were almost completely unresponsive to restimulation with fresh spleen cells and antigen ( Fig.  2 A) . This inability to proliferate upon restimulation was a long-lasting phenotype, since the T cells remained unrespon- (Fig. 2 B) . In contrast, T cells that had been preincubated with irradiated spleen cells and antigen proliferated as well as freshly isolated 2.102 cells at this timepoint (Fig.  2 B) . The observed lack of proliferation upon antigenic challenge could not be explained by cell death, since equivalent numbers of cells were recovered whether or not peptide was present during the initial stimulus with fixed APC (Fig. 2 legend). Moreover, both anergic and nonanergic Th2 cells could proliferate equivalently in response to exogenously added IL-2 when combined with anti-CD3 mAb stimulation to upregulate surface levels of the IL-2R, further indicating that cell death did not account for the unresponsiveness to antigen stimulation in the anergic T cells (Table 1) .
Th2 Cells Are Made Anergic after Stimulation by Altered Peptide Ligand and Live APC.
We have previously shown that stimulation of Thl clones with live APC and APL, which allows partial T cell activation but not proliferation, leads (Fig. 3) . These data therefore confirm that Th2 cells, which are sensitive to anergy induction by antigen presentation with chemically fixed APC, can be made anergic after partial activation by peptide analog and live APC. This extends our observation of anergy induction with live APC and APL in Thl cells to include Th2 clones.
It was important to determine if anergy could be extended to other Th2 clones, or if it was a unique property of 2.102 cells. Thus, we examined the response ofEW5X, a Th2 clone with identical peptide/MHC specificity as 2.102 but expressing a distinct TCR (Hsu, B.L., and P.M. Allen, unpublished observations). EW5X cells, like 2.102 cells, did not proliferate when presented with antigen by fixed APC while being stimulated to produce II.-4 and IL-3. After such an initial stimulation, EW5X cells displayed an anergic phenotype, being unable to proliferate to live APC and immunogenic peptide (Fig.  2 C) . Thus, the unresponsive state induced after antigen pre- sentation by chemically fixed APC could be shown for multiple Th2 clones. It was also important to determine if our Th2 clones differ from those of others reported in the literature to be resistant to anergy induction (2), or if our protocol could render such T cells anergic. To address this issue, we examined the tolerance susceptibility of the well-characterized Th2 clone D10 (28) under identical experimental conditions, using the conalbumin immunogenic peptide (residues 132-146) as antigen (21) . Like 2.102, D10 cells did not proliferate when presented with antigen by chemically fixed APC (Fig. 4 A) . Upon anal-),sis of the cytokines produced, it was found that, whereas antigen presented by irradiated APC stimulated significant amounts of IL-3 and IL-4 by D10, antigen presentation by fixed APC failed to stimulate any detectable levels of either cytokine (Fig. 4 B and data not shown) . Therefore, in contrast to the phenotype observed with 2.102, D10 showed no indication of being partially activated by antigen and fixed APC. Moreover, after such an initial stimulation, D10 calls were able to proliferate normally when restimulated by antigen and irradiated APC, thus failing to display an anergic phenotype (Fig. 4 C) . These results were consistent with previous literature and led us to conclude that there must be a phenotypic difference between our Th2 clones and D10 that accounts for the difference in tolerance susceptibility.
Tke Anergic Tk2 Cells Can Still Make Cytokines upon Restimulation.
The observation that the Th2 clones were able to make cytokines in response to antigen presentation by fixed APC suggested that the signaling requirements for cytokine production and proliferation differ, with a fixation-sensitive component necessary only to activate proliferation. It was of interest to investigate if the anergic Th2 cells could still produce cytokines upon restimulation. To test this, 24-h supernatants were collected from the restimulation assay described in Fig. 2 and analyzed for cytokine production. In contrast to their inability to proliferate upon restimulation, we found that the anergic Th2 cells were still able to produce IL-4 and IL-3, albeit at slightly reduced levels compared with unanergized Th2 cells (Pig. 5, A and B). These data raise two interesting points. First, the signaling pathway leading to proliferation is distinct from that leading to cytokine production in Th2 cells, with only the proliferation pathway containing a component sensitive to inactivation. Second, anergic Th2 cells, unlike anergic Thl cells, retain the capacity to make their autocrine growth factor, but have lost the ability to respond to it.
Th2 Anergl/ is Cydosporine A Sensitiw Since Thl anergy can be prevented if cyclosporine A is added with the anergyinducing stimulus (14, 15) , and since Th2 proliferation and 1L-4 production can be inhibited by cyclosporine A (35, SloanLancaster, J., unpublished observations), it was of interest to investigate if Th2 anergy was similarly sensitive to inhibition by this drug. 2.102 cells were therefore preincubated with fixed APC and peptide with or without cyclosporine A and then analyzed for their ability to proliferate upon restimulation with fresh APC and antigen. As shown in Fig. 6 , the addition of this drug to the preculture prevented the Th2 cells from becoming anergic, indicating that Th2 anergy, like Thl anergy, is cydosporine A sensitive. This observation suggests that the signaling pathway involved in Th2 cell anergy involves a calcineurin-dependent step.
Addition of Exogenous Costimulation or Growth Factors Does Not Prevent Th2 Clonal Anergy. Following the paradigm of
Thl anergy by fixed APC, we examined the involvement of costimulation in Th2 anergy. IL-1 is well documented as a candidate costimulatory factor for Th2 cells (5-7). To determine if this cytokine was a costimulator for 2.102, the response of these T cells upon antigen presentation by fixed APC was compared with or without the addition of exogenous rlL-1B. Although fixed APC and antigen alone did not Figure 5 . Cytokine production of anergic Th2 cells upon restimuladon with antigen. 2.102 ceils were stimuhted as in Fig. 2 A, and supernatams were collected from the challenge assay at 24 h and analyzed for presence of IL-4 (A) and IL3 (/3) by bioassay using the II.,4-dependent 614 (A) or IL-3-dependent GG-1.12 (B) cell lines. Cell recoveries after anergy induction stage, expressed as a percentage of input cell number, were 40% for no peptide group and 44% for Hb(64-76) group. The points represent the mean of triplicate cultures + SD. Each experiment is a representative of three independent assays. Peptide Concentration (gM) Figure 6 . Th2 anergy is prevented by cy~losporine A. 2.102 cells were used in the tolerance assay as in Fig. 2 A, . 7 B) . These results led us to conclude that, whereas IL-1 can substitute for the missing factor required for Th2 proliferation in response to antigen presentation by fixed APC, its absence in the initial culture is not responsible for indudng the anergic state. This appears to be in contrast to the role played by CD28 in the Thl system, where ligation of CD28 is capable both of activating proliferation to antigen presented by fixed APC and preventing anergy induction to such a stimulus (3, Sloan-Lancaster, J., unpublished observations).
Thus, it appears that we can induce an anergic state in a Th2 cell when the stimulus it is provided allows the cell to proliferate: i.e., IL-1 as a costimulus is suffxient to restore proliferation to but not to prevent anergy induction by antigen and fixed APC. Whether the anergic Th2 cells can recover from the unresponsive state if allowed to proliferate in the absence of antigen was not addressed in this experiment. We next investigated the effect of adding various growth factors to the primary culture with antigen and fixed APC to assess their effect, if any, on the anergic state. Addition of exogenous IL-2 or IL-4 with antigen and fixed APC did not pre- Where indicated, either Ib2 or IL-4 (20 U/ml) were included. T cells were then reco~red and challenged in a proliftrarion assay using 5 • 104 T calls/well and Hb(64-76) ix-pride to stimulate. Fresh unmaaipuhted T cells were added as a control in C. Cell recoveries after the tolerance induction stage, expressed as a petr.entage of input cell number, were as follows: (B) 100% for irradiated/Hb group, 65% for fixed/Hb group and 65% for fixed/ Hb/rII,1B group; (C) 54% for fi.,md/Hb/IL,4 group, 357% for irradiated/ Hb/Ib4 group, 91.5% for fixed/Hb/Ib2 group, and 380% for irradiated/Hb/Ib2 group. Each point represents the mean of triplicate (A) or duplicate (B and C) cultures • SD. Experiments are representatives of >10 (/1) and 4 (B and C) independent assays. vent the resulting unresponsiveness, whereas their addition with live APC and antigen did not diminish the subsequent proliferative response upon restimulation (Fig. 7 C) .
A study demonstrated that T cells of the Th0 phenotype could be made anergic after TCK engagement in the absence of costimulatory factors (19) . The anergic phenotype was characterized by inhibition of IL-2 production and inability to proliferate while still producing IL-4. Since some of the Th0 clones used in the study produced low levels of IL-2, we wanted to rule out the possibility that the 2.102 clone may be making low levels of IL-2. Using three different assays, we convincingly demonstrated that 2.102 T cells do not make IL-2 and are bona fide Th2 cells. First, to examine the growth factor dependence of 2.102, blocking mAbs specific for IL-2 or IL-4 were added to the culture during a proliferation assay.
Whereas the anti-IL-4 mAb inhibited the proliferation of 2.102 completely, anti-IL-2 mAb failed to diminish the response (Fig. 8 A) . Second, supematant from activated 2.102 cells could support the growth of the CTLL cell line, which was completely inhibited by anti-IL-4 mAb (Fig. 1 B) . Finally, analysis by RT-PCR of the cytokine mRNA present after stimulation of 2.102, with either peptide/APC or anti-CD3 mAb, revealed an activation-dependent synthesis of IL-4 mRNA but no detectable IL-2 mRNA (Fig. 8 B) . In contrast, the T cell hybridoma G2, made from a fusion of the 2.102 clone, produced detectable IL-2 and IL-4 mRNAs upon activation, consistent with the detection of IL-2 protein from this hybridoma by bioassay (Fig. 8 B) . Moreover, when the mRNA synthesis pattern of a lysozyme-specific Th0 clone (Yule, T. D., and P. M. Allen, unpublished observations) was analyzed, constitutive IL-4 mRNA and activation-dependent IL-2 mRNA patterns were found (data not shown). In summary, these data confirm that 2.102 is a Th2 done, since no IL-2 dependence or detection of IL-2 production by these T cells could be demonstrated. 
Discussion
This report demonstrates that Th2 clones, similar to Thl cells, are susceptible to anergy induction in vitro. Specifically, we show that ddivery of an initial incomplete signal, which allows cytokine production in the absence of clonal expansion, results in a profoundly tolerant state. The phenotype of tolerant Th2 cells resembles that of anergic Thl cells in several ways. These include an inability to proliferate in an antigen-specific manner while still able to divide if provided exogenous IL-2 (10, 15), maintenance of the ability to produce cytokines and exert effector functions (2, 36, and SloanLancaster, J., unpublished observations), and susceptibility of the anergy induction pathway to cydosporine A (14, 15) . Furthermore, the anergic phenotype for both T cell subsets appears to be a long-lived state (10, 15) . These observations unify Thl and Th2 cells with regard to anergy and suggest that inhibition of proliferation is the fundamental control mechanism used for anergy for both T cell subsets. This prevention of donal expansion is therefore an important pathway for controlling amplification of the immune response.
Although there are many similarities in the phenotypes of tolerant Thl and Th2 cells, there are also some striking differences. First, anergic Th2 cells retain the capacity to make their autocrine growth factor, but they have lost the ability to respond to it. The hallmark of Thl anergy is that the cells are unable to make IL-2 upon restimulation, yet provision of exogenous IL-2 activates vigorous proliferation (10) . This indicates that anergic Thl cells have normal expression of functional IL-2R, and that their defect is in the ability to synthesize the autocrine growth factor. In contrast, the anergic Th2 cells described here retain the ability to synthesize IL-4, but no longer proliferate to it. This phenotype might be achieved by a downregulation of surface IL-4R or a functional uncoupling of the IL-4R from its intracellular signaling pathway. Alternatively, the inability to proliferate in the presence of sufficient IL-4 may reflect a defect or absence of a second factor required by the cells to enter the cell cycle. In support of this, several studies have shown that TCR engagement can activate IL-4 production without inducing Th2 cell proliferation (28, 34) . The different phenotypes of anergy in the two call subsets may reflect different stringencies of regulation of the genes encoding their respective growth factors, since several studies indicate that IL-2, but not IL-4, gene activation requires costimulation in addition to TCR engagement (4, 6, 37) . Thus, Th2 cells may have evolved a mechanism to become unresponsive that does not involve the inactivation of their autocrine growth factor.
Second, the two Th subsets differ in that the addition of exogenous costimulation does not prevent Th2 anergy induced by chemically fixed APC (10) . Ahhough IL-1 functions as a costimulatory factor for some Th2 cells (5-7; Fig.  7 A) , it had no effect on the anergy induction for 2.102 (Fig.  7 B) . This observation indicates that exogenous IL-1 is not the natural costimulation utilized by these T calls and ultimately required by them to continually expand. Intrigningly, a recent report has demonstrated that CD28 can function as a costimulator for Th2 clones, presumably by inducing endogenous IL-1 production from the T cells (38) . It is thus conceivable that the source of IL-1 in the system may be critical, such that lack of endogenous T cell IL-1 gene activation during TCR engagement leads to subsequent anergy. Although our initial studies indicate that CD28 activation does not prevent anergy of our Th2 ceils (Sloan-Lancaster, J., unpublished observations), some other receptor-ligand interaction (e.g., CTLA4-B7-1, -B7-2) may provide such a function to allow endogenous T cell IL-1 production (39-44).
Our previous studies demonstrated that Thl clones could be made tolerant by presentation of an APL and live APC (15) . The phenotype of this tolerant state apparently differs from that induced after antigen presentation with fixed APC, since only in the latter situation can anergy be prevented by addition of exogenous costimulation (14) . In this report, we demonstrate Th2 anergy induced both by antigen presentation with fixed APC and by APL presentation with live APC. Ahhough our initial studies indicate that the anergic phenotype resulting from either stimulation appears to be the same, further investigation must be undertaken to assess this. Moreover, the relationship between the signals involved in Thl and Th2 anergy is unknown at this point.
Several studies have previously demonstrated a failure to tolerize Th2 clones (17, 18) . Several potential variables may account for these different experimental findings. These could include the individual antigen specificities, costimulatory dependencies, and level of maturity of the various cells used in the studies. In support of this, Th0 cells are susceptible to tolerance induction, losing the ability to produce IL-2 and proliferate while still able to produce IL-4 (19) . The phenotype of these T cells is similar to that of our Th2 clones, in that they lose the ability to respond to IL-4. Moreover, a recent study has demonstrated tolerance induction in vivo, in both the Thl-and Th2-like subpopulations (45) . It is argued that the precursors of the Th2 cells, rather than the mature Th2 cells themselves, are susceptible to tolerance induction in this case. It is possible that the Th2 population is less vulnerable to anergy signals than the Thl population, and that this resistance becomes more prominent as the ceUs progress in their lineage. One could imagine that established T call clones can represent ceils at different levels of maturity, a reflection of which cell lineage stage the precursor had progressed to when it was cloned. Thus, Th2 clones that are susceptible to tolerance-inducing stimuli, while still exerting a defined Th2 phenotype ( Fig. 1 B and Fig. 8 ), would represent ceils closer in lineage to Th0 cells than toleranceresistant Th2 cells (Hg. 4). A comparison of the phenotypes of representatives from the two respective populations could potentially provide insight into this possibility.
If a peripheral tolerance system is designed to deal with sdf-antigen-spedfic T cells that have escaped thymic tolerance, all T cell populations should be included for it to be efficient. To date, Th0, Thl, and CD8 + T cells have been shown to become anergic (10, 19, 46) . Thus, it is reasonable to assume that Th2 ceils would also be susceptible to in vitro tolerance induction. Although unable to proliferate, anergic T cells retain the ability to produce significant levels of cytokines and carry out effector functions upon restimulation. Specifically, anergic Thl, Th0, and Th2 ceUs still make cytokines (2, 19 , and data shown here), whereas anergic Thl cells and CD8 + T cells retain cytolytic function (36, 46) . These observations raise the question of the efficacy, and therefore relevance, of functional anergy in an in vivo setting. However, the immune system depends greatly on donal expansion for amplification of any response to become effective in a local environment. We propose, therefore, that the ablation of this ability by T cells is a highly efficient way of controlling an autoimmune response in vivo. In support of this, a similar T cell phenotype was found in a system using hen egg white lysozyme (HEL) as a neo-self-antigen. T cell clones generated from HEL-tnnsgeuic mice displayed poorer proliferation, but equivalent cytokine production profiles, when compared with T call clones generated from nontransgenic littermates (47) . The transgenic mice showed no signs of autoreactivity, but displayed in vivo tolerance to the neo-selfantigen, demonstrating that limitation of donal expansion is sufficient for the control of an autoimmune response. In summary, this report demonstrates that Th2 cells, like all other T cell clonal populations, are susceptible to anergy induction in vitro, and implicates an involvement of these cells during control of self-reactive lymphocytes in vivo.
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